Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
21
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
14.3%
3 terminated/withdrawn out of 21 trials
82.4%
-4.1% vs industry average
24%
5 trials in Phase 3/4
0%
0 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.
Role: collaborator
Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study
Role: collaborator
Participation and Detection Rate of Screening CT Colonography and Screening Sigmoidoscopy
Role: lead
The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.
Role: lead
Tomosynthesis Versus Digital Mammography in a Population-based Screening Program
Role: lead
Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Role: collaborator
Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia
Role: collaborator
High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients
Role: collaborator
STI.VI. Study: How to Improve Lifestyles in Screening Contexts
Role: lead
Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Role: collaborator
A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)
Role: collaborator
Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma
Role: collaborator
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
Role: collaborator
Zevalin Twice in Aggressive Non-Hodgkin Lymphoma
Role: collaborator
Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma
Role: collaborator
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Role: collaborator
Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
Role: collaborator
Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
Role: collaborator
Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma
Role: collaborator
The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community
Role: collaborator